Compare BWFG & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BWFG | YDES |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 475.4M | 543.0M |
| IPO Year | 2014 | N/A |
| Metric | BWFG | YDES |
|---|---|---|
| Price | $62.21 | $2.24 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $55.00 | N/A |
| AVG Volume (30 Days) | 81.7K | ★ 312.1K |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 261.79 | N/A |
| EPS | ★ 1.41 | N/A |
| Revenue | ★ $2,826,000.00 | N/A |
| Revenue This Year | $17.64 | N/A |
| Revenue Next Year | $6.21 | N/A |
| P/E Ratio | $42.96 | ★ N/A |
| Revenue Growth | ★ 43.96 | N/A |
| 52 Week Low | $38.20 | $1.70 |
| 52 Week High | $61.86 | $25.00 |
| Indicator | BWFG | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 66.73 | 44.84 |
| Support Level | $45.62 | $2.14 |
| Resistance Level | N/A | $3.05 |
| Average True Range (ATR) | 1.87 | 0.32 |
| MACD | 0.09 | 0.07 |
| Stochastic Oscillator | 95.77 | 59.36 |
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.